002001 新和成
已收盘 05-07 15:00:00
资讯
新帖
简况
山西证券:给予新和成买入评级
证券之星 · 05-04
山西证券:给予新和成买入评级
每周股票复盘:新 和 成(002001)新和成2026年Q1营收增15.72%
证券之星 · 05-03
每周股票复盘:新 和 成(002001)新和成2026年Q1营收增15.72%
新和成(002001)2026年一季报简析:增收不增利
证券之星 · 04-30
新和成(002001)2026年一季报简析:增收不增利
图解新和成一季报:第一季度单季净利润同比下降2.80%
证券之星 · 04-29
图解新和成一季报:第一季度单季净利润同比下降2.80%
新和成(002001)披露2026年第一季度报告,4月28日股价上涨2.49%
证券之星 · 04-28
新和成(002001)披露2026年第一季度报告,4月28日股价上涨2.49%
新和成(002001)披露2025年年度报告,4月27日股价下跌0.78%
证券之星 · 04-27
新和成(002001)披露2025年年度报告,4月27日股价下跌0.78%
东兴证券:给予新和成买入评级
证券之星 · 04-17
东兴证券:给予新和成买入评级
新和成(002001)披露2025年年度股东会通知,4月15日股价下跌4.14%
证券之星 · 04-15
新和成(002001)披露2025年年度股东会通知,4月15日股价下跌4.14%
新和成:2025年净利润67.64亿元同比增长15.26%
证券之星 · 04-15
新和成:2025年净利润67.64亿元同比增长15.26%
4月7日新和成涨5.95%,医药ETF易方达基金重仓该股
证券之星 · 04-07
4月7日新和成涨5.95%,医药ETF易方达基金重仓该股
【机构调研记录】大同证券调研新和成
证券之星 · 03-23
【机构调研记录】大同证券调研新和成
股市必读:新 和 成(002001)3月20日披露最新机构调研信息
证券之星 · 03-23
股市必读:新 和 成(002001)3月20日披露最新机构调研信息
突发涨价潮!维生素价格跳涨超35%,盈利拐点真的来了?
中金财经 · 03-19
突发涨价潮!维生素价格跳涨超35%,盈利拐点真的来了?
3月11日新和成涨6.53%,易方达沪深300医药ETF基金重仓该股
证券之星 · 03-11
3月11日新和成涨6.53%,易方达沪深300医药ETF基金重仓该股
3月6日新和成涨8.07%,易方达沪深300医药ETF基金重仓该股
证券之星 · 03-06
3月6日新和成涨8.07%,易方达沪深300医药ETF基金重仓该股
股市必读:新 和 成(002001)2月27日董秘有最新回复
证券之星 · 03-02
股市必读:新 和 成(002001)2月27日董秘有最新回复
新和成(002001)披露2026年度第一期科技创新债券发行结果公告,2月3日股价上涨4.42%
证券之星 · 02-03
新和成(002001)披露2026年度第一期科技创新债券发行结果公告,2月3日股价上涨4.42%
华夏稳定双利债券C基金经理变动:张海静不再担任该基金基金经理
中金财经 · 01-31
华夏稳定双利债券C基金经理变动:张海静不再担任该基金基金经理
新和成(002001)披露第五期员工持股计划完成非交易过户,1月26日股价上涨0.18%
证券之星 · 01-26
新和成(002001)披露第五期员工持股计划完成非交易过户,1月26日股价上涨0.18%
【私募调研记录】景林资产调研新和成
证券之星 · 01-26
【私募调研记录】景林资产调研新和成
加载更多
公司概况
公司名称:
浙江新和成股份有限公司
所属行业:
医药制造业
上市日期:
2004-06-25
主营业务:
浙江新和成股份有限公司的主营业务是营养品、香精香料、高分子材料、原料药生产和销售。公司的主要产品是维生素类、氨基酸类、色素类、芳樟醇系列、柠檬醛系列、叶醇系列、二氢茉莉酮酸甲酯、覆盆子酮、女贞醛、薄荷醇、聚苯硫醚(PPS)、高温尼龙(PPA)、HDI、IPDA、维生素系列、抗生素系列、医药中间体系列。公司是全国精细化工百强企业、中国轻工业香料行业十强企业和知名的特种工程塑料生产企业。
发行价格:
13.41
{"stockData":{"symbol":"002001","market":"SZ","secType":"STK","nameCN":"新和成","latestPrice":32.25,"timestamp":1778137428000,"preClose":33.98,"halted":0,"volume":74556696,"delay":0,"changeRate":-0.0509,"floatShares":3037000000,"shares":3073000000,"eps":2.1838,"marketStatus":"已收盘","change":-1.73,"latestTime":"05-07 15:00:00","open":33.9,"high":33.9,"low":32.01,"amount":2411000000,"amplitude":0.0556,"askPrice":32.25,"askSize":67,"bidPrice":32.24,"bidSize":125,"shortable":0,"etf":0,"ttmEps":2.1838,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778203800000},"marketStatusCode":5,"adr":0,"adjPreClose":33.98,"symbolType":"stock","openAndCloseTimeList":[[1778117400000,1778124600000],[1778130000000,1778137200000]],"highLimit":37.38,"lowLimit":30.58,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3073421680,"isCdr":false,"pbRate":2.97,"roa":"--","peRate":14.767836,"roe":"5.37%","epsLYR":2.21,"committee":0.046092,"marketValue":99118000000,"turnoverRate":0.0246,"status":1,"floatMarketCap":97939000000},"requestUrl":"/m/hq/s/002001","defaultTab":"news","newsList":[{"id":"2632093680","title":"山西证券:给予新和成买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2632093680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632093680?lang=zh_cn&edition=full","pubTime":"2026-05-04 15:35","pubTimestamp":1777880127,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司冀泳洁近期对新和成进行研究并发布了研究报告《业绩符合预期,维生素、氨基酸价格大幅上涨》,给予新和成买入评级。最新盈利预测明细如下:该股最近90天内共有19家机构给出评级,买入评级16家,增持评级3家;过去90天内机构目标均价为48.5。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050400001182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002001","002500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608891","title":"每周股票复盘:新 和 成(002001)新和成2026年Q1营收增15.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608891","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608891?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:53","pubTimestamp":1777765987,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,新 和 成报收于34.8元,较上周的34.8元上涨0.0%。本周,新 和 成4月27日盘中最高价报35.6元。本周关注点来自业绩披露要点:新和成2026年Q1营收62.95亿元,同比增15.72%。来自公司公告汇总:2026年Q1归母净利润18.27亿元,同比下降2.80%。股本股东变化截至2026年3月31日,公司股东户数为7.9万户,较2025年12月31日增加652户,增幅0.83%。2025年度现金分红总额和股份回购总额占归母净利润比例为53.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631154520","title":"新和成(002001)2026年一季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2631154520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631154520?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:27","pubTimestamp":1777501631,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期新和成发布2026年一季报。根据财报显示,新和成增收不增利。截至本报告期末,公司营业总收入62.95亿元,同比上升15.72%,归母净利润18.27亿元,同比下降2.8%。本次财报公布的各项数据指标表现一般。持有新和成最多的基金为医药ETF易方达,目前规模为172.15亿元,最新净值0.373,较上一交易日上涨0.35%,近一年上涨6.32%。天津尼龙项目目前正常建设中,预计 2027 年建成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000020503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0405327148.USD","BK0187","BK0191","LU0405327494.USD","BK0070","BK0188","BK0197","BK0239","002001","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531075","title":"图解新和成一季报:第一季度单季净利润同比下降2.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531075","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631531075?lang=zh_cn&edition=full","pubTime":"2026-04-29 05:30","pubTimestamp":1777411850,"startTime":"0","endTime":"0","summary":"证券之星消息,新和成2026年一季报显示,一季度公司主营收入62.95亿元,同比上升15.72%;归母净利润18.27亿元,同比下降2.8%;扣非净利润17.76亿元,同比下降5.51%;负债率25.64%,投资收益8510.07万元,财务费用1.44亿元,毛利率42.88%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900012367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630583646","title":"新和成(002001)披露2026年第一季度报告,4月28日股价上涨2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630583646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630583646?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:06","pubTimestamp":1777385163,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘,新和成报收于35.39元,较前一交易日上涨2.49%,最新总市值为1087.68亿元。近日,浙江新和成股份有限公司披露2026年第一季度报告。报告显示,公司2026年第一季度实现营业收入62.95亿元,同比增长15.72%;归属于上市公司股东的净利润为18.27亿元,同比下降2.80%;扣除非经常性损益后的净利润为17.76亿元,同比下降5.51%。截至2026年3月31日,公司总资产为474.55亿元,较年初增长4.05%;归属于上市公司股东的所有者权益为351.32亿元,较年初增长7.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800064040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0191","BK0239","BK0028","BK0197","BK0070","BK0187","LU0405327494.USD","LU0405327148.USD","002001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630347364","title":"新和成(002001)披露2025年年度报告,4月27日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630347364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630347364?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:37","pubTimestamp":1777282629,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,新和成报收于34.53元,较前一交易日下跌0.78%,最新总市值为1061.25亿元。该股当日开盘34.83元,最高35.6元,最低34.35元,成交额达9.55亿元,换手率为0.9%。近日,新和成披露《2025年年度报告(英文版)》。公告显示,公司2025年实现营业总收入22,251,361,880.58元,同比增长2.97%;归属于上市公司股东的净利润为6,764,199,225.29元;第四季度经营活动产生的现金流量净额为3,155,242,421.67元。截至2025年末,公司资产总额为13,065,505,952.26元,负债总额为3,823,658,770.70元,所有者权益合计9,241,847,181.56元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700032664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0197","BK0028","LU0405327494.USD","BK0191","BK0239","BK0188","BK0187","002001","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628204952","title":"东兴证券:给予新和成买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2628204952","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628204952?lang=zh_cn&edition=full","pubTime":"2026-04-17 14:15","pubTimestamp":1776406517,"startTime":"0","endTime":"0","summary":"东兴证券股份有限公司刘宇卓近期对新和成进行研究并发布了研究报告《业绩稳健增长,新项目新产品提供发展新动能》,给予新和成买入评级。 公司盈利预测及投资评级:新和成是国内优质的精细化工合成龙头,产业链一体化和产品系列化推动公司逐渐成长为精细化工龙头。维持“强烈推荐”评级。最新盈利预测明细如下:该股最近90天内共有10家机构给出评级,买入评级8家,增持评级2家;过去90天内机构目标均价为49.31。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700022899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601198","002001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627238443","title":"新和成(002001)披露2025年年度股东会通知,4月15日股价下跌4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627238443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627238443?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:09","pubTimestamp":1776262155,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘,新和成报收于36.59元,较前一交易日下跌4.14%,最新总市值为1124.56亿元。该股当日开盘37.78元,最高37.88元,最低36.06元,成交额达20.15亿元,换手率为1.82%。近日,浙江新和成股份有限公司发布《关于召开2025年年度股东会的通知》。公告显示,公司将于2026年5月15日召开2025年年度股东会,会议采取现场表决与网络投票相结合的方式,股权登记日为2026年5月7日。中小投资者表决结果将单独计票,部分提案涉及关联股东回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500042941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0197","002001","BK0239","BK0188","LU0405327148.USD","BK0028","LU0405327494.USD","BK0191","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627283030","title":"新和成:2025年净利润67.64亿元同比增长15.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627283030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627283030?lang=zh_cn&edition=full","pubTime":"2026-04-15 18:30","pubTimestamp":1776249026,"startTime":"0","endTime":"0","summary":"新和成(002001.SZ)发布2025年年度报告,实现营业收入222.51亿元,同比增长2.97%;归属于上市公司股东的净利润为67.64亿元,同比增长15.26%。公司拟向全体股东每10股派发现金红利8.00元(含税),送红股0股,不以资本公积金转增股本。注:公司Q4净利润14.43亿,Q3净利润17.17亿,据此计算,Q4净利润环比下降15%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500035600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625933785","title":"4月7日新和成涨5.95%,医药ETF易方达基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625933785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625933785?lang=zh_cn&edition=full","pubTime":"2026-04-07 16:21","pubTimestamp":1775550087,"startTime":"0","endTime":"0","summary":"证券之星消息,4月7日新 和 成涨5.95%,收盘报38.08元,换手率2.01%,成交量61.17万手,成交额22.87亿元。重仓新 和 成的前十大公募基金请见下表:该股最近90天内共有8家机构给出评级,买入评级6家,增持评级2家;过去90天内机构目标均价为48.26。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共47家,其中持有数量最多的公募基金为易方达基金的医药ETF易方达。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700021928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["512010","BK0070","LU0405327494.USD","LU0405327148.USD","002001","BK0028","BK0187","BK0197","BK0239","BK0191","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621747307","title":"【机构调研记录】大同证券调研新和成","url":"https://stock-news.laohu8.com/highlight/detail?id=2621747307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621747307?lang=zh_cn&edition=full","pubTime":"2026-03-23 08:02","pubTimestamp":1774224150,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及3月20日披露的机构调研信息,大同证券近期对1家上市公司进行了调研。调研上市公司名单如下:1)新 和 成 调研纪要:2026年公司以“拓市增量、创新发展、智造赋能、提质增效”为经营指导思想,坚持稳中求进。公司可生产8种维生素,多种产品价格提升。生物发酵产品包括维生素C、辅酶Q10及多种氨基酸,未来将拓展至香料和新材料领域。公司通过战略采购等方式保障原料供应,成本波动影响可控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300002152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002001","BK0028","BK0191","LU0405327494.USD","BK0239","BK0187","LU0405327148.USD","BK0197","BK0070","BK0188","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621474329","title":"股市必读:新 和 成(002001)3月20日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2621474329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621474329?lang=zh_cn&edition=full","pubTime":"2026-03-23 01:30","pubTimestamp":1774200633,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,新 和 成报收于34.25元,下跌0.15%,换手率1.48%,成交量45.05万手,成交额15.52亿元。当日关注点来自交易信息汇总:3月20日主力资金净流出2655.42万元,游资与散户资金分别净流入1830.59万元和824.83万元。公司通过战略采购、集中采购、长协合作等方式保障原材料供应稳定,核心原料供应不受价格波动显著影响,近期主要产品市场价格亦有上涨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU0405327148.USD","LU0405327494.USD","BK0028","BK0070","BK0191","BK0188","002001","BK0187","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620246290","title":"突发涨价潮!维生素价格跳涨超35%,盈利拐点真的来了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620246290","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620246290?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:00","pubTimestamp":1773914401,"startTime":"0","endTime":"0","summary":"核心品种价格持续走高从具体品类来看,维生素A、维生素E成为本轮涨价的核心品种,涨幅明显且传导迅速。在成本端上游化工原料涨价,以及油运价格上涨等因素刺激下,业内控产涨价意愿强烈。机构扎堆调研维生素价格上涨快速传导至资本市场,产业链上市公司成为机构关注的重点标的,调研次数大幅增加。维生素品类价格自去年第四季度以来已实现企稳回升。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/19/20260319780631.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/19/20260319780631.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260319/32081868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0070","BK0226","603079","BK0188","BK0201","BK0197","002626","BK0191","603676","002562","BK0077","LU0405327148.USD","LU0405327494.USD","BK0186","BK0239","BK0028","002001","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618128249","title":"3月11日新和成涨6.53%,易方达沪深300医药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618128249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618128249?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:22","pubTimestamp":1773217322,"startTime":"0","endTime":"0","summary":"证券之星消息,3月11日新 和 成涨6.53%创60日新高,收盘报38.67元,换手率2.42%,成交量73.64万手,成交额27.98亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共47家,其中持有数量最多的公募基金为易方达基金的易方达沪深300医药ETF。易方达沪深300医药ETF目前规模为169.74亿元,最新净值0.3744,较上一交易日上涨2.02%,近一年上涨4.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100026255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["512510","512880","BK0187","510880","BK0191","BK0188","BK0028","BK0070","000688.SH","LU0405327148.USD","000905.SH","000300.SH","BK0197","515890","399001","159967","LU0405327494.USD","BK0239","002001","399006","510300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617111683","title":"3月6日新和成涨8.07%,易方达沪深300医药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617111683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617111683?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:27","pubTimestamp":1772785639,"startTime":"0","endTime":"0","summary":"证券之星消息,3月6日新 和 成涨8.07%创60日新高,收盘报36.3元,换手率2.99%,成交量90.9万手,成交额32.28亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共47家,其中持有数量最多的公募基金为易方达基金的易方达沪深300医药ETF。易方达沪深300医药ETF目前规模为169.74亿元,最新净值0.3624,较上一交易日上涨0.61%,近一年上涨1.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600025944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399001","LU0405327494.USD","BK0028","000905.SH","BK0188","BK0191","BK0070","BK0187","002001","BK0239","399006","000688.SH","BK0197","510880","159967","515890","000300.SH","510300","512880","LU0405327148.USD","512510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616873941","title":"股市必读:新 和 成(002001)2月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616873941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616873941?lang=zh_cn&edition=full","pubTime":"2026-03-02 01:17","pubTimestamp":1772385430,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,新 和 成报收于31.5元,上涨1.42%,换手率1.9%,成交量57.68万手,成交额18.17亿元。董秘最新回复投资者: 有媒体报道,近期公司将50%饲料级VE 出口报价上调 15%至 7.5美元/公斤,是否属实?产品报价根据市场、行业、客户等多因素进行调整,谢谢!交易信息汇总资金流向2月27日主力资金净流出2309.77万元;游资资金净流入11.2万元;散户资金净流入2298.57万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200000564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002001","BK0188","LU0405327148.USD","BK0070","BK0197","BK0191","BK0239","LU0405327494.USD","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608872421","title":"新和成(002001)披露2026年度第一期科技创新债券发行结果公告,2月3日股价上涨4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608872421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608872421?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:09","pubTimestamp":1770127746,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘,新和成报收于27.4元,较前一交易日上涨4.42%,最新总市值为842.12亿元。该股当日开盘26.66元,最高27.49元,最低26.0元,成交额达12.38亿元,换手率为1.52%。近日,浙江新和成股份有限公司披露《2026年度第一期科技创新债券发行结果公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300042946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","LU0405327148.USD","LU0405327494.USD","BK0197","BK0191","BK0239","002001","BK0188","BK0028","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607780720","title":"华夏稳定双利债券C基金经理变动:张海静不再担任该基金基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2607780720","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607780720?lang=zh_cn&edition=full","pubTime":"2026-01-31 10:03","pubTimestamp":1769824998,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年1月31日,华夏稳定双利债券(288102)发布公告,张海静不再担任该基金基金经理,离任日期为2026年1月31日,变更后华夏稳定双利债券(288102)的基金经理为陆晓天,武文琦。截止2026年1月30日,华夏稳定双利债券净值为2.8397,较上一日下跌0.22%,近一年上涨1.48%。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260131/31989145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","002001","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606246135","title":"新和成(002001)披露第五期员工持股计划完成非交易过户,1月26日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606246135","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606246135?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:15","pubTimestamp":1769436944,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘,新和成报收于28.0元,较前一交易日上涨0.18%,最新总市值为860.56亿元。近日,浙江新和成股份有限公司披露《关于第五期员工持股计划实施进展的公告》。公告显示,公司于2026年1月26日完成第五期员工持股计划非交易过户,21,454,310股公司股份以24.19元/股价格从回购专户过户至员工持股计划账户,占总股本0.6981%。员工持股计划放弃股东表决权,与控股股东不构成一致行动关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600035527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0188","BK0187","BK0239","LU0405327494.USD","002001","BK0197","BK0028","BK0191","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606726191","title":"【私募调研记录】景林资产调研新和成","url":"https://stock-news.laohu8.com/highlight/detail?id=2606726191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606726191?lang=zh_cn&edition=full","pubTime":"2026-01-26 08:00","pubTimestamp":1769385659,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月23日披露的机构调研信息,知名私募景林资产近期对1家上市公司进行了调研,相关名单如下:1)新 和 成 调研纪要:2025年公司营养品价格受供需影响波动,维生素价格已企稳回升,蛋氨酸需求稳步增长。这些考虑是上海景林做投资决定和估值过程中的核心。上海景林所管理的基金均给投资人创造了丰厚的长期回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026012600001871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","LU0405327148.USD","LU0405327494.USD","BK0197","BK0028","BK0187","BK0070","002001","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778199500132,"stockEarnings":[{"period":"1week","weight":-0.0733},{"period":"1month","weight":-0.1531},{"period":"3month","weight":0.084},{"period":"6month","weight":0.2563},{"period":"1year","weight":0.505},{"period":"ytd","weight":0.2803}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0745},{"period":"3month","weight":0.0282},{"period":"6month","weight":0.0457},{"period":"1year","weight":0.2505},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江新和成股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"78970人(较上一季度减少48.94%)","perCapita":"38455股","listingDate":"2004-06-25","address":"浙江省绍兴市新昌县七星街道新昌大道西路418号","registeredCapital":"307342万元","survey":" 浙江新和成股份有限公司的主营业务是营养品、香精香料、高分子材料、原料药生产和销售。公司的主要产品是维生素类、氨基酸类、色素类、芳樟醇系列、柠檬醛系列、叶醇系列、二氢茉莉酮酸甲酯、覆盆子酮、女贞醛、薄荷醇、聚苯硫醚(PPS)、高温尼龙(PPA)、HDI、IPDA、维生素系列、抗生素系列、医药中间体系列。公司是全国精细化工百强企业、中国轻工业香料行业十强企业和知名的特种工程塑料生产企业。","listedPrice":13.41},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新和成(002001)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新和成(002001)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新和成,002001,新和成股票,新和成股票老虎,新和成股票老虎国际,新和成行情,新和成股票行情,新和成股价,新和成股市,新和成股票价格,新和成股票交易,新和成股票购买,新和成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新和成(002001)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新和成(002001)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}